Campothecin (CPT), an anticancer drug, may cause early pregnancy loss and fetal growth restriction via up regulation of its target gene, 19/March/2015, 18.36

Campothecin (CPT), an anticancer drug, may cause early pregnancy loss and fetal growth restriction via up regulation of its target gene, 19/March/2015, 18.36

Campothecin (CPT), an anticancer drug, may cause early pregnancy loss and fetal growth restriction via up regulation of its target gene, 19/March/2015, 18.36 150 150

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Web: http://genomediscovery.org

Significance:  This study suggests, for the first time, that Campothecin (CPT), by increasing the expression of its target gene, it may cause early pregnancy loss and fetal growth restriction. Thus, physicians may take this finding into consideration while treating pregnant women with Campothecin.

Citation: Boominathan,  Campothecin (CPT), an anticancer drug, may cause early pregnancy loss and fetal growth restriction via up regulation of its target gene, 19/March/2015,  18.36, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How Campothecin (CPT) causes early pregnancy loss and fetal growth restriction

* Research cooperation

Share
Start Typing